Assessing the Completeness of Adverse Event Reporting in Clinical Trials of Psoriasis Treatments: A Registry-Publication Comparison Study.
- DOI
- 10.1007/s40261-026-01561-z
- Published
- 2026 Jul
- Container
- Clinical drug investigation
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s40261-026-01561-z,
title = {Assessing the Completeness of Adverse Event Reporting in Clinical Trials of Psoriasis Treatments: A Registry-Publication Comparison Study.},
author = {Rowe M and Dinh M and Sherry R and Keefer K and Hazlitt R and Elghzali A and Archer D and Ford AI and Vassar M},
year = {2026},
journal = {Clinical drug investigation},
doi = {10.1007/s40261-026-01561-z},
url = {https://doi.org/10.1007/s40261-026-01561-z}
}RIS
TY - JOUR TI - Assessing the Completeness of Adverse Event Reporting in Clinical Trials of Psoriasis Treatments: A Registry-Publication Comparison Study. AU - Rowe M AU - Dinh M AU - Sherry R AU - Keefer K AU - Hazlitt R AU - Elghzali A AU - Archer D AU - Ford AI AU - Vassar M PY - 2026 JO - Clinical drug investigation DO - 10.1007/s40261-026-01561-z UR - https://doi.org/10.1007/s40261-026-01561-z ER -
APA
M, R., M, D., R, S., K, K., R, H., A, E., D, A., AI, F., & M, V. (2026). Assessing the Completeness of Adverse Event Reporting in Clinical Trials of Psoriasis Treatments: A Registry-Publication Comparison Study.. Clinical drug investigation. https://doi.org/10.1007/s40261-026-01561-z
Source records
- pubmed · retrieved 2026-09-26T05:22:18.472Z